Stone Clinical Laboratories LLC, a CAP accredited and CLIA certified laboratory in New Orleans, Louisiana, is excited to announce that it will soon be in a position to provide coronavirus (COVID-19) testing services. Stone will be accepting specimens and be able to begin testing effective March 19, 2020. The testing will be able to detect 2019 Novel Coronavirus (COVID-19), using Real Time PCR testing platform.
“We feel privileged to bring this service to the community during this pandemic,” said Stone Clinical Laboratories’ founder and CEO, Christopher Ridgeway. “Our team is working diligently to continue to provide the industry’s highest standards of quality, accuracy, and consistency to those affected by this national health crisis.”
Founded in 2016 in New Orleans, Louisiana, Stone Clinical Laboratories is a full-service clinical reference laboratory that specializes in preventative and molecular diagnostics testing. Stone focuses on simplifying testing, improving the efficiency of molecular diagnostics, reducing consumer and corporate cost, and increasing overall access to innovative diagnostics and the quality of patient care. Stone uses PCR-based molecular testing to detect infectious diseases and other DNA/RNA based testing, while continually enhancing its offerings in complementary diagnostic services including chemistry, microbiology, pharmacogenetic, hematology and prescription drug monitoring.